UK GLP-1 price trends in 2026: what's moved and why
GLP-1 price trends in 2026 have a clear shape: the entry point is getting cheaper, the maintenance doses are not, and the gap between the cheapest and the dearest provider for the exact same pen has barely closed. This report reads the 4 July 2026 snapshot of 24 regulated UK online pharmacies and sets it against what has been publicly happening to Mounjaro and Wegovy supply and list pricing over the year.
One caveat up front, because we are a data desk: our board is a point-in-time index, not a decade of tick data. Where we quote a direction of travel we say what it rests on. Where we only have today's number, we give you today's number and leave it there.
The three GLP-1 price trends that define 2026
Strip the noise and the market is moving in three directions at once. They pull against each other, which is why a single "prices are up" or "prices are down" headline is useless.
1. Starter doses are the loss leader
The first four weeks are now where pharmacies compete hardest. The cheapest Mounjaro 2.5 mg starter promo on the board is £122 (Chemist4U), against a median ongoing 2.5 mg price of £170. On Wegovy, the starter 0.25 mg dose drops to a low of £80 (Boots Online Doctor) versus a median of £104. That is a deliberate hook: the starter dose is a four-week trial, not a treatment dose, and providers price it to win the first order.
2. Maintenance prices crept, not dropped
The doses you actually stay on tell a colder story. Mounjaro 15 mg — a full maintenance dose — carries a low of £289 and a median of £318. Wegovy 2.4 mg sits at a £175 low and a £200 median. These are the numbers that decide your annual cost, and they have not followed the starter promos down. If anything, the headline discounting on entry doses is subsidised by steady maintenance pricing further up the ladder.
3. The spread refuses to close
The single most durable trend is dispersion. Across the six Mounjaro doses the same-dose spread averages about £77; across the five injectable Wegovy doses it averages about £79. This is the same pen, the same medicine, the same regulator — priced up to £90 apart at Wegovy 1 mg (£109 low to £199 high). A market that had truly commoditised would compress that gap. It has not.
Where the market sits now, dose by dose
Here is the current picture the trends are moving through — the low print, the median and the top print across all 24 providers for the doses people ask about most. Every figure is the ongoing (non-promo) price from our 4 July 2026 check.
| Dose | Low | Median | High | Spread |
|---|---|---|---|---|
| Mounjaro 2.5 mg starter | £146 | £170 | £229 | £83 |
| Mounjaro 5 mg | £174 | £190 | £259 | £85 |
| Mounjaro 15 mg top dose | £289 | £318 | £359 | £70 |
| Wegovy 0.25 mg starter | £80 | £104 | £164 | £84 |
| Wegovy 1 mg | £109 | £148 | £199 | £90 |
| Wegovy 2.4 mg maintenance | £175 | £200 | £249 | £74 |
Ongoing prices, 24 UK providers, checked 4 July 2026. Starter rows show the treatment-dose figure; promo entry prices go lower again. Confirm the live price on the provider's own site.
The Weight Clinic — our pick for people staying on treatment
Trends favour the buyer who thinks past month one. The Weight Clinic runs monthly video reviews so your dose is actually managed as you climb the ladder, includes needles, and refunds you if a prescriber declines. Its Mounjaro 2.5 mg starter is £125 with code NEWME (£35 off your first order), and ongoing maintenance prices sit at or below the market median.
Why the numbers moved the way they did
Three forces explain the shape of 2026, and none of them is a mystery.
Supply normalised. The Wegovy and Mounjaro shortages that defined earlier years have largely eased for UK private supply, and pharmacies that once rationed pens now compete for them. Competition on a normalised supply shows up first at the entry dose, because that is where new patients are won.
List pricing set a floor. Manufacturer list prices and the wholesale cost of a pen put a hard floor under how low the maintenance doses can realistically go. That is why the starter war can rage while 15 mg Mounjaro barely twitches — there is simply less margin to give away at the top of the ladder.
An oral option arrived. 2026 is the year an oral GLP-1 route entered the UK conversation. Our dataset now carries a Wegovy pill line alongside the injectables. It is early, provider coverage is thin, and it does not yet drag injection prices around — but it is the first structural change to the menu in a while, and worth watching rather than acting on today.
What the trends mean for what you pay
The practical takeaway is unromantic. Because the spread has not closed, the provider you choose still swings your annual cost by hundreds of pounds — more than any month-to-month trend will. And because starter promos are a loss leader, a headline entry price tells you almost nothing about the two, six or twelve months that follow.
So price the thing you will actually be on. If you expect to reach 10 mg Mounjaro, the number that matters is the 10 mg price, not the 2.5 mg promo. Our homepage board sorts every provider by ongoing price at any dose, and the cheapest-by-dose tracker gives you the low print at each rung of the ladder.
Two more reports round out the picture. If you want the full monthly market read behind these trends, see the July 2026 price index. And because cheap-per-month is not the same as cheap-per-result, our cost-per-percentage-point analysis divides real prices by trial-average weight loss — useful when a dearer drug loses more weight per pound.
FAQ: GLP-1 price trends in 2026
Are GLP-1 prices going up or down in 2026?
Both, depending on the dose. Starter-dose promos have deepened — the cheapest Mounjaro 2.5 mg entry price is £122 — while maintenance doses have crept up or held, with Mounjaro 15 mg at a £289 low and a £318 median. The entry point is getting cheaper; the doses you stay on are not.
Why is the same medicine so much cheaper at one pharmacy than another?
It is the same pen and the same regulator, but pharmacies buy, price and bundle differently. In our 4 July 2026 snapshot the same-dose spread averages roughly £77–£79, and reaches £90 at Wegovy 1 mg (£109 to £199). Choosing the right provider saves more than waiting for prices to move.
Should I wait for prices to fall further before starting?
The trend does not support waiting. Maintenance prices are not falling, and the buyer-friendly action in 2026 is at the entry dose, which you can access now. This is price information, not medical advice — whether and when to start is a decision for a qualified prescriber, not a price chart.
Does the new Wegovy pill change injection prices?
Not yet. An oral GLP-1 route entered the UK menu in 2026 and now appears in our dataset, but provider coverage is thin and it is not dragging injectable prices around. It is a structural change worth watching rather than a reason to change plans today.
How current are these price trends?
Every figure here comes from our board of 24 regulated UK providers, last checked 4 July 2026. Prices move between checks — always confirm the live figure on the provider's own site before ordering.
Buying past the promo? Start with The Weight Clinic
The trends reward the buyer who prices maintenance, not month one. The Weight Clinic is our pick for exactly that: monthly video reviews so your dose is managed as you climb, needles included, and a full refund if a prescriber declines. New patients get £35 off with code NEWME.